Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Immunohistochemistry × Clear all

Status

Completed 8 Terminated 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tobacco Use Disorder 1 Precancerous Conditions 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hodgkin Disease 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1

Interventions

Gemcitabine 63 Fluorouracil 22 130-nm albumin-bound paclitaxel 19 Oxaliplatin 18 Leucovorin 13 Capecitabine 13 S 1 (combination) 12 Albumin-Bound Paclitaxel 12 Taxes 9 Radiosurgery 9 folfirinox 8 Irinotecan 8 Radiotherapy 6 Cisplatin 6 pembrolizumab 5 Pancreaticoduodenectomy 5 Drug Therapy 5 irinotecan sucrosofate 4 apatinib 4 Radiofrequency Ablation 4 Paclitaxel 4 Injections 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 Stents 3 Sorafenib 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03820921 2019-01-29

SUCCESS

Ponderas Academic Hospital

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡